No registrations found.
ID
Source
Brief title
Health condition
Childhood constipion
Sponsors and support
Intervention
Outcome measures
Primary outcome
Rectal fecal impaction evaluated by rectal examination/abdominal x-ray.
Secondary outcome
1. Defecation frequency/week;
2. Fecal incontinence frequency/week;
3. The number of side effects, such as abdominal pain, bloating, flatulence, nausea, bad taste;
4. Total and segmental colonic transit time.
Background summary
Enema versus high doses of PEG 3350 in the treatment of fecal impaction
“the Leopard Study”.
Background:
Fecal retention with stasis (impaction) of stools in the rectum is a common symptom of childhood constipation. Fecal impaction is defined as severe constipation with a large fecal mass which is unlikely to be passed on demand. It includes a dilated rectum filled with a large amount of (usually) hard stool, noted either by abdominal palpation or rectal examination. The conventional therapy in these children is rectal enemas followed by a maintenance dose of PEG. The purpose of this study is to investigate whether high dose of PEG solution is more efficient in the treatment of rectal fecal impaction. If so the need for rectal enemas will diminish significantly and will lead to another guideline for the first line treatment of these children.
It is suggested that a distended rectum slows down the motor activity of the colon and that an inhibitory recto-colonic feedback mechanism exists. The effect of the rectal distension due to fecal impaction on the colonic motility is not understood. To evaluate the latter mechanism in children with rectal fecal stasis the effect of fecal impaction on the CTT in these children will be investigated, by assessing the difference between the CTT in a non-prepared impacted rectum and the CTT during clearance of fecal impaction with intensive laxative therapy.
Aim:
1. To investigate the efficacy of high doses of PEG 3350 versus rectal enemas in the treatment of fecal impaction in children with chronic constipation.
2. To assess whether the colonic transit time is longer during fecal impaction than when the impaction is resolved.
Study population:
Ninety children (4-18 years) with constipation referred to the outpatient clinic at Emma Children’s Hospital/AMC with evidence of rectal fecal impaction will be offered to enroll in the study.
Methods:
This is a prospective randomized controlled study, with a non-inferiority design.
Abdominal and rectal examination is acquired by the physician to define the presence of fecal impaction, which is defined as a large fecal mass of hard stools in the rectum. After intake, on 6 consecutive days, all patients will ingest 1 capsule with 10 radio-opaque markers to assess the colonic transit time. During these days, no laxative medication will be given and a diary is filled out by child and parents. On day 7 an abdominal radiograph is obtained.
Subsequently on day 8 the disimpaction therapy will be started with either 6 days of enemas or 6 days of PEG, according to randomization. A diary is filled out by child and parents. During this study period the colonic transit time will be measured again, according to the above described method. On day 14, a second abdominal radiograph is obtained. The presence or absence of fecal impaction is assessed by abdominal and rectal examination. Thereafter, all patients receive laxative medication (enemas or PEG 3350) according to their defecation pattern and symptoms. A second follow-up visit will be scheduled on day 28 and diaries will be reviewed regarding symptoms and possible adverse effects.
Study objective
1. High dose of PEG is more effective and more tolerable in the treatment of fecal impaction compared to rectal enemas;
2. Fecal impaction results in a delayed colonic transit time, which will improve during successful disimpaction.
Study design
N/A
Intervention
At intake a standardized questionnaire is obtained by a physician to the parents and patient. Physical examination, including abdominal and rectal examination is acquired by the physician to define the presence of fecal impaction. Fecal impaction is defined as a large fecal mass of hard stools in the rectum.
After intake, on 6 consecutive days, all patients will ingest 1 capsule with 10 radio-opaque markers to assess the colonic transit time. During these days, no laxative medication will be given and a diary is filled out by child and parents. On day 7 an abdominal radiograph is obtained.
Subsequently on day 8 the disimpaction therapy will be started with either 6 days of enemas or 6 days of PEG, according to randomization. A diary is filled out by child and parents. This diary concerns topics on defecation pattern, fecal incontinence, abdominal pain and possible side effects of administered medications. During this study period the colonic transit time will be measured again, according to the above described method.
On day 14, a second abdominal radiograph is obtained to measure colonic transit time. The presence or absence of fecal impaction is assessed by abdominal and rectal examination as well as by the second abdominal X-ray.
Thereafter, all patients receive laxative medication (enemas or PEG 3350) according to their defecation pattern and symptoms. A second follow-up visit will be scheduled on day 28 and diaries will be reviewed regarding symptoms and possible adverse effects.
P.O. Box 22660
Marc A. Benninga
Meibergdreef 9
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5663053 / +31 (0)20 5666297
m.a.benninga@amc.nl
P.O. Box 22660
Marc A. Benninga
Meibergdreef 9
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5663053 / +31 (0)20 5666297
m.a.benninga@amc.nl
Inclusion criteria
1. Age 4-18 years;
2. Fecal impaction upon rectal exam.
Exclusion criteria
1. Previous colonic surgery;
2. Organic cause of constipation;
3. Allergy/sensitivity to PEG solutions or phosphates;
4. Allergy/sensitivity to sodium ducosate or sorbitol (“Klyx” enema).
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL546 |
NTR-old | NTR602 |
Other | : N/A |
ISRCTN | ISRCTN71579145 |